IL1B and chronic kidney disease: Next, in a separate cohort of mice, we injected WT-CKD mice weekly with either anti–IL-1β antibody or IgG as a placebo (5 mg/kg, i.p.), starting 3 weeks after the second nephrectomy (Figure 7B).